Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Alverix, Beckman, Boehringer, Clint, collateral, command, comparison, Coulter, Coumadin, covenant, crystallize, curtail, CytoCore, defense, dehydrogenase, earnout, erosion, exceptionally, failed, Fisher, fraudulent, genetic, Glucose, heard, HemoSense, indemnify, Italy, lastly, Latin, left, Mannheim, MAST, MDA, Mellon, overpayment, phosphate, pledged, portable, proceeding, proud, rationalization, Reidy, resumed, reverted, Severson, sickle, slightly, stroke, tenure, Thermo, Thornton, unfavourable, unjustly, warfarin, weaker, wrongful
Filing tables
Filing exhibits
TRIB similar filings
Filing view
External links
Exhibit 15.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Trinity Biotech plc
Trinity Biotech plc
We consent to the incorporation by reference in the registration statements on Form F-3 (333-113091, 333-112568, 333-116537, 333-103033, 333-107363 and 333-114099) and in the registration statements on Form S-8 (33-76384, 333-220, 333-5532, 333-7762 and 333-124384) of Trinity Biotech plc of our report dated April 2, 2008, with respect to the consolidated balance sheet of Trinity Biotech plc as of December 31, 2007, and the related consolidated statements of operations, recognised income and expense, and cash flows for each of the years in the two-year period ended December 31, 2007, which report appears in the December 31, 2008 annual report on Form 20-F of Trinity Biotech plc.
KPMG
Dublin, Ireland
Dublin, Ireland
April 7, 2009